<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 1</issue_number>
<issue_period>2015 (January - March)</issue_period>
<title>CHANGING PARADIGM OF ENTEROCOCCAL INFECTIONS </title>
<abstract>Enterococci are increasingly recognized as an important nosocomial pathogen. The present study was done to establish the changing paradigm of blood culture enterococcal isolates and emergence of  lessThan i greaterThan Enterococcus faecium  lessThan /i greaterThan as a nosocomial pathogen. A total of 150 Enterococcal isolates were obtained during the study period from January 2013 to March 2014. 68.3% and 31.7% of adult and 53% and 43% of paediatric blood culture enterococcal isolates were  lessThan i greaterThan Enterococcus faecalis  lessThan /i greaterThan and  lessThan i greaterThan Enterococcus faecium  lessThan /i greaterThan respectively. Antimicrobial susceptibility testing by Kirby Bauer disc diffusion revealed vancomycin resistance of 7.2% and 1.8% for adult 15.3% and 26 % among the paediatric  lessThan i greaterThan E. faecalis lessThan /i greaterThan  and  lessThan i greaterThan E. faecium lessThan /i greaterThan  isolates respectively. The present study demonstrates the changing spectrum of enterococcal species causing bacteremia and increasing prevalence of vancomycin resistance among  lessThan i greaterThan E. faecium lessThan /i greaterThan  isolates. This emphasises the need for speciation of various enterococcal isolates and knowledge of antimicrobial resistance profile is necessary for management of serious enterococcal infections.</abstract>
<authors>MAANASA M BHASKAR AND HARISH B. N</authors>
<keywords>VRE â€“ Vancomycin resistant enterococci,  HLG- high level gentamicin,  MDR- multidrug resistant, CLSI- clinical and laboratory standard institute, MIC- minimum inhibitory concentration,</keywords>
<pages>579-584</pages>
</article>
</Journal>
